ABOUT US > What's New
What's New
April
Chemical Names of Previously Controlled Fentanyl-Related Substances (April 19, 2019)
Temporary Order: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I (April 16, 2019)
Proposed Rule: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I (April 8, 2019)
Importer of Controlled Substances Registration (April 8, 2019)
Bulk Manufacturer of Controlled Substances Registration (April 8, 2019)
Synthcon, LLC (April 8, 2019)
Martin A. Barrios, M.D.; Decision and Order (April 8, 2019)
Craig M. Weingrow, M.D.; Decision and Order (April 8, 2019)
Richard Carter, M.D.; Decision and Order (April 8, 2019)
Sanyal Biotechnology, LLC (April 8, 2019)
SpecGx LLC (April 8, 2019)
Organic Standards Solutions International, LLC (April 8, 2019)
Unither Manufacturing LLC (April 8, 2019)
March
Siemens Healthcare Diagnostics Inc. (March 21, 2019)
Fisher Clinical Services, Inc. (March 21, 2019)
Joel A. Smithers, D.O.; Decision and Order (March 18, 2019)
William A. Sanpablo, M.D.; Decision and Order (March 18, 2019)
Sharp (Bethlehem), LLC (March 18, 2019)
Importer of Controlled Substances Registration (March 6, 2019)
Bulk Manufacturer of Controlled Substances Registration (March 6, 2019)
Patheon Pharmaceuticals, Inc. (March 6, 2019)
S&B Pharma Inc. (March 6, 2019)
Siegfried USA, LLC (March 1, 2019)
Meridian Medical Technologies (March 1, 2019)
February
30-Day Notice: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 (February 27, 2019)
Proposed Rule: New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222) (February 21, 2019)
Ajay S. Ahuja, M.D.; Decision and Order (February 21, 2019)
Importer of Controlled Substances Registration (February 21, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 21, 2019)
Johnson Matthey, Inc. (February 21, 2019)
Navinta LLC (February 21, 2019)
Noramco, Inc. (February 21, 2019)
Stepan Company (February 21, 2019)
Research Triangle Institute (February 21, 2019)
Curium US, LLC (February 20, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 11, 2019)
Robert T. Perez, M.D.; Decision and Order (February 11, 2019)
Miles J. Nelson, M.D.; Decision and Order (February 11, 2019)
Paul Surinder Singh, D.O.; Decision And Order (February 11, 2019)
PerkinElmer, Inc. (February 11, 2019)
Stepan Company (February 11, 2019)
Almac Clinical Services Incorp (ACSI) (February 11, 2019)
Importer of Controlled Substances Registration (February 7, 2019)
Bulk Manufacturer of Controlled Substances Registration (February 7, 2019)
IsoSciences, LLC (February 7, 2019)
Kinetochem, LLC (February 7, 2019)
Johnson Matthey Pharmaceutical Materials, Inc. (February 7, 2019)
Research Triangle Institute (February 7, 2019)
Microgenics Corporation Thermo Fisher Scientific (February 7, 2019)
Chattem Chemicals (February 7, 2019)
Kurt L. Pflieger, M.D.; Order Dismissing Order To Show Cause (February 7, 2019)
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction (February 7, 2019)
January 2019
Placement of MAB-CHMINACA in Schedule I (January 29, 2019)
December 2018
Notice of Intent: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I (December 28, 2018)
Importer of Controlled Substances Registration (December 27, 2018)
Stephen R. Kovacs, D.O.; Decision and Order (December 27, 2018)
Johnson Matthey Inc. (December 27, 2018)
Myoderm (December 27, 2018)
Agilent Technologies (December 27, 2018)
Usona Institute (December 14, 2018)
Arizona Department of Corrections (December 14, 2018)
Usona Institute (December 14, 2018)
Eli-Elsohly Laboratories (December 13, 2018)
Cambrex High Point, Inc. (December 13, 2018)
Siegfried USA, LLC (December 13, 2018)
Mylan Pharmaceuticals Inc. (December 13, 2018)
Noramco Inc. (December 13, 2018)
Mylan Technologies, Inc. (December 13, 2018)
Bulk Manufacturer of Controlled Substances Registration (December 6, 2018)
Decision and Order: Zelideh I. Cordova-Velazco, M.D. (December 6, 2018)
Exempt Chemical Preparations Under the Controlled Substances Act (December 3, 2018)
November
Steve Fanto, M.D.; Decision and Order (November 30, 2018)
Narciso A. Reyes, M.D.; Decision and Order (November 30, 2018)
Final Order: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I (November 29, 2018)
Importer of Controlled Substances Registration (November 27, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 27, 2018)
Noramco Inc. (November 27, 2018)
Insys Manufacturing, LLC (November 27, 2018)
Cayman Chemical Company (November 27, 2018)
Akorn, Inc. (November 27, 2018)
Cambridge Isotope Laboratories (November 27, 2018)
GE Healthcare (November 27, 2018)
Fisher Clinical Services, Inc. (November 27, 2018)
Sigma Aldrich Co., LLC (November 27, 2018)
Organix, Inc. (November 20, 2018)
Patheon API Manufacturing, Inc. (November 20, 2018)
Edward A. Ridgill, M.D.; Decision and Order (November 20, 2018)
Eldor Brish, M.D.; Decision and Order (November 20, 2018)
Lipomed (November 20, 2018)
Janssen Pharmaceuticals Inc. (November 20, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 9, 2018)
Chattem Chemicals (November 9, 2018)
Bulk Manufacturer of Controlled Substances Registration (November 2, 2018)
Janssen Pharmaceuticals, Inc. (November 2, 2018)
